TCL Archive Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program October 26, 1979
TCL Archive Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer January 25, 2013
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
